Evidence map›Paper›PMID 35746724›Full record

ArticleViruses2022

Construction of a Dengue NanoLuc Reporter Virus for In Vivo Live Imaging in Mice.

Enyue Fang, Xiaohui Liu, Miao Li, Jingjing Liu, Zelun Zhang, Xinyu Liu, Xingxing Li, Wenjuan Li, Qinhua Peng, Yongxin Yu and 1 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Evolution of Zika virus inVirus evolution · 2025
    Article
  2. Reporter-expressing viruses for antiviral drug discovery research.Frontiers in cellular and infection microbiology · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Enyue FangDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.ORCID 0000-0003-0140-5731
Xiaohui LiuDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Miao LiDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Jingjing LiuDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Zelun ZhangDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Xinyu LiuDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Xingxing LiDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Wenjuan LiDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Qinhua PengDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Yongxin YuDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.
Yuhua LiDepartment of Arbovirus Vaccine, National Institutes for Food and Drug Control, Beijing 102629, China.ORCID 0000-0003-3806-8046
National Institutes for Food and Drug Control · CNWuhan Institute of Bioengineering · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first isolation in 1943, the dengue virus (DENV) has spread throughout the world, but effective antiviral drugs or vaccines are still not available. To provide a more stable reporter DENV for vaccine development and antiviral drug screening, we constructed a reporter DENV containing the NanoLuc reporter gene, which was inserted into the 5' untranslated region and capsid junction region, enabling rapid virus rescue by in vitro ligation. In addition, we established a live imaging mouse model and found that the reporter virus maintained the neurovirulence of prototype DENV before engineering. DENV-4 exhibited dramatically increased neurovirulence following a glycosylation site-defective mutation in the envelope protein. Significant mice mortality with neurological onset symptoms was observed after intracranial infection of wild-type (WT) mice, thus providing a visualization tool for DENV virulence assessment. Using this model, DENV was detected in the intestinal tissues of WT mice after infection, suggesting that intestinal lymphoid tissues play an essential role in DENV pathogenesis.

Indexed as

DengueDengue VirusAnimalsAntiviral AgentsGenes, ReporterLuciferasesMiceAntiviral AgentsLuciferasesnanolucflavivirusin vivo imagingneurovirulencereporter virus

Identifiers

PMID35746724
PMCPMC9230669
OpenAlexW4282575275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.